148 related articles for article (PubMed ID: 17620)
1. Studies on the mechanism of ristocetin-induced platelet agglutination. Effects of structural modification of ristocetin and vancomycin.
Coller BS; Gralnick HR
J Clin Invest; 1977 Aug; 60(2):302-12. PubMed ID: 17620
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ristocetin-induced platelet agglutination by vancomycin.
Moake JL; Cimo PL; Peterson DM; Roper P; Natelson EA
Blood; 1977 Sep; 50(3):397-406. PubMed ID: 301760
[TBL] [Abstract][Full Text] [Related]
3. [Ability of vancomycin-group antibiotics to induce or to inhibit thrombocyte agglutination].
Rák K; Boda Z; Sztaricskai F
Antibiotiki; 1980 Aug; 25(8):595-606. PubMed ID: 6250464
[TBL] [Abstract][Full Text] [Related]
4. The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility.
Coller BS
J Clin Invest; 1978 May; 61(5):1168-75. PubMed ID: 307006
[TBL] [Abstract][Full Text] [Related]
5. Study of platelet agglutination induced by the antibiotics of the vancomycin group: ristocetin, ristomycin, actinoidin and vancomycin.
Boda Z; Solum NO; Sztaricskai F; Rak K
Thromb Haemost; 1979 Dec; 42(4):1164-80. PubMed ID: 232315
[No Abstract] [Full Text] [Related]
6. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
Moore A; Ross GD; Nachman RL
J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
[TBL] [Abstract][Full Text] [Related]
7. Neutralization of the local negative charge carried by glycoprotein (GP)-Ib in ristocetin-induced platelet agglutination.
Tanoue K; Jung SM; Yamamoto N; Yamazaki H
Thromb Haemost; 1984 Feb; 51(1):79-83. PubMed ID: 6232731
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of ristocetin-induced platelet agglutination: binding of ristocetin to platelets.
Jenkins CS; Clemetson KJ; Lüscher EF
J Lab Clin Med; 1979 Feb; 93(2):220-31. PubMed ID: 311800
[TBL] [Abstract][Full Text] [Related]
9. Agglutination of formalin-fixed, platelet-type von Willebrand's disease platelets by human von Willebrand factor.
Takahashi H; Shibata A
Thromb Haemost; 1984 Dec; 52(3):267-70. PubMed ID: 6241752
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of von Willebrand factor-induced platelet agglutination by ADP does not result from reduced binding of total von Willebrand factor or its larger multimers.
Zucker MB; Puszkin EG; Sussman II; Mauss EA
J Lab Clin Med; 1990 Sep; 116(3):305-14. PubMed ID: 2401846
[TBL] [Abstract][Full Text] [Related]
11. A study of the possible interactions between human platelets and the antibiotic MDL-507 (teicoplanin).
Porta M; Ricchetti I
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):661-4. PubMed ID: 2950065
[TBL] [Abstract][Full Text] [Related]
12. Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin.
Coller BS
Blood; 1980 Feb; 55(2):276-81. PubMed ID: 6766335
[TBL] [Abstract][Full Text] [Related]
13. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
Mills DC; Hunchak K; Karl DW; Kirby EP
Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
[TBL] [Abstract][Full Text] [Related]
14. Interaction of platelets, von Willebrand factor, and ristocetin during platelet agglutination.
Moake JL; Olson JD; Troll JH; Weinger RS; Peterson DM; Cimo PL
J Lab Clin Med; 1980 Jul; 96(1):168-84. PubMed ID: 6967100
[TBL] [Abstract][Full Text] [Related]
15. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
16. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V.
Kang M; Wilson L; Kermode JC
Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030
[TBL] [Abstract][Full Text] [Related]
17. Ristocetin-induced platelet agglutination stimulates GPIIb/IIIa-dependent calcium influx.
Bertolino G; Noris P; Spedini P; Balduini CL
Thromb Haemost; 1995 Apr; 73(4):689-92. PubMed ID: 7495080
[TBL] [Abstract][Full Text] [Related]
18. Membrane fluidity and platelet aggregation: dibucaine permits ristocetin-induced platelet aggregation with low-molecular-weight von Willebrand multimers.
Gjønnaess E; Solum NO; Brosstad F
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):395-405. PubMed ID: 1420815
[TBL] [Abstract][Full Text] [Related]
19. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib.
Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D
Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906
[TBL] [Abstract][Full Text] [Related]
20. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
